Hubei Guangji Pharmaceutical Co Ltd - Asset Resilience Ratio
Hubei Guangji Pharmaceutical Co Ltd (000952) has an Asset Resilience Ratio of 5.37% as of September 2020. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (1999–2011)
This chart shows how Hubei Guangji Pharmaceutical Co Ltd's Asset Resilience Ratio has changed over time. Check 000952 strategic asset allocation to assess the company's strategic physical and investment asset allocation.
Liquid Assets Composition Over Time
This chart breaks down Hubei Guangji Pharmaceutical Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see market cap of Hubei Guangji Pharmaceutical Co Ltd.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 0% |
| Short-term Investments | CN¥110.00 Million | 5.37% |
| Total Liquid Assets | CN¥110.00 Million | 5.37% |
Asset Resilience Insights
- Limited Liquidity: Hubei Guangji Pharmaceutical Co Ltd maintains only 5.37% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Hubei Guangji Pharmaceutical Co Ltd Industry Peers by Asset Resilience Ratio
Compare Hubei Guangji Pharmaceutical Co Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Biogen Inc
NASDAQ:BIIB |
Drug Manufacturers - General | 2.74% |
|
Pfizer Inc
SA:PFIZ34 |
Drug Manufacturers - General | 5.48% |
|
AstraZeneca PLC
NYSE:AZN |
Drug Manufacturers - General | 0.10% |
|
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SHG:600436 |
Drug Manufacturers - General | 17.40% |
|
Aurora Optoelectronics Co Ltd
SHG:600666 |
Drug Manufacturers - General | 5.89% |
|
NanJing Pharmaceutical Co Ltd
SHG:600713 |
Drug Manufacturers - General | 0.85% |
|
Dimed S.A. Distribuidora de Medicamentos
SA:PNVL3 |
Drug Manufacturers - General | 7.83% |
|
Firebrick Pharma Ltd
AU:FRE |
Drug Manufacturers - General | 0.29% |
Annual Asset Resilience Ratio for Hubei Guangji Pharmaceutical Co Ltd (1999–2011)
The table below shows the annual Asset Resilience Ratio data for Hubei Guangji Pharmaceutical Co Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2011-12-31 | 0.00% | CN¥42.25K ≈ $6.18K |
CN¥1.51 Billion ≈ $220.47 Million |
-1.33pp |
| 2006-12-31 | 1.34% | CN¥10.50 Million ≈ $1.54 Million |
CN¥785.02 Million ≈ $114.87 Million |
+0.20pp |
| 2005-12-31 | 1.13% | CN¥10.00 Million ≈ $1.46 Million |
CN¥882.44 Million ≈ $129.13 Million |
+0.04pp |
| 2004-12-31 | 1.10% | CN¥10.00 Million ≈ $1.46 Million |
CN¥911.95 Million ≈ $133.45 Million |
-0.17pp |
| 2003-12-31 | 1.27% | CN¥11.00 Million ≈ $1.61 Million |
CN¥866.94 Million ≈ $126.86 Million |
-2.43pp |
| 2000-12-31 | 3.70% | CN¥25.00 Million ≈ $3.66 Million |
CN¥676.22 Million ≈ $98.95 Million |
-0.93pp |
| 1999-12-31 | 4.62% | CN¥30.00 Million ≈ $4.39 Million |
CN¥648.78 Million ≈ $94.94 Million |
-- |
About Hubei Guangji Pharmaceutical Co Ltd
Hubei Guangji Pharmaceutical Co., Ltd. manufactures and sells pharmaceutical raw materials, pharmaceutical preparations, and feed additives in China and internationally. It also exports its products. The company was founded in 1969 and is based in Wuxue, China.